Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl‐2 Genes

1 Oct 1998

Abstract excerpt

Deregulated expression of one or more growth control genes including p16, p53, EGF receptor (EGFR), MDM2 or Bcl-2 may contribute to the treatment resistance phenotype of GBM and generally poor patient survival. Clinically, GBM have been divided into two major groups defined by (1) histologic progression from a low grade tumor ("progressive" or "secondary" GBM) contrasted with (2) those which show initial clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Glioma Diagnosis and Treatment
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9804374
DOI: 10.1111/j.1750-3639.1998.tb00191.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl‐2 GenesPMID 9804374Read ↗

Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 AlterationSemantic proximity Read ↗

Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.Semantic proximity Read ↗

Prognostic impact of molecular markers in a series of 220 primary glioblastomasSemantic proximity Read ↗

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.Semantic proximity Read ↗

Diversity of cytogenetic and pathohistologic profiles in glioblastoma.Semantic proximity Read ↗

Genetic profile of gliosarcomas.Semantic proximity Read ↗

Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma MultiformeSemantic proximity Read ↗

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.Semantic proximity Read ↗

Determination of p53 Mutations, EGFR Overexpression, and Loss of p16 Expression in Pediatric GlioblastomasSemantic proximity Read ↗

Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.Semantic proximity Read ↗

Amplification and Overexpression of MDM2 in Primary (de novo) GlioblastomasSemantic proximity Read ↗

Age-dependent prognostic effects of genetic alterations in glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.